Recent developments in the field of diabetes treatment have introduced a promising class of medications known as GLP-1 receptor agonists. These agents work by mimicking the effects of glucagon-like peptide-1 (GLP-1), a https://jadaevoj881467.popup-blog.com/39700687/new-glp-1-receptor-agonists-semaglutide-tirzepatide-and-retatrutide